書籍詳細

第I章 小児癌をめぐる最新トピックス

P.16 掲載の参考文献

• 1) Sutow WW, West E : Studies on Nagasaki (Japan) children exposed in utero to the atomic bomb : A roentgenographic survey of the skeletal system. Am. J Roentgenol. Radium. Ther. Nucl. Med., 74 : 493-499, 1955.

• 2) Sutow WW : Skeletal maturation in healthy Japanese children, 6 to 19 years of age, comparison with Skeletal maturation in American children, Hiroshima. J. Med. Sci., 2 : 181-191, 1953.

• 3) Ohwada K, Sutow WW : Skeletal maturation in healthy Japanese children 6 to 19 years of age. Shonika Rinsho (in Japanese) 6 : 738-746, 1953.

• 4) Reynolds EL : Growth and development of Hiroshima children exposed to the atomic bomb : Three-year study (1951-1953). AECC. Technical. Report., 20-59, 1959.

• 5) Nehemias JV : Multivariate analysis and the IBM 704 computer applied to ABCC data on growth of surviving children. Hiroshima. ABCC. Technical. Report., 22-61, 1961.

• 6) Belsky JL, Blot WJ : Stature of adults exposed in childhood to the atomic bombs, Hiroshima-Nagasaki, ABCC. 7 : Technical. Report., 35-71, 1971.

• 7) Sutow WW, Terasaki T, Ohwada K : Comparison of skeletal maturation with dental status in Japanese children. : Pediatrics., 14 : 327-333, 1954.
  pubmed

• 8) Sutow WW, Pryde A : Incidence of spina bifida occulta in relation to age. J. Dis. Child., 91 : 211-217, 1956.

• 9) Sutow WW : Endocrine factors in growth and development in childhood and adolescence. Horumon to Rinsho (in Japanese) 2 : 704-719, 1954.

• 10) Sutow WW, Moloney WC, Margoles C : Kernicterus in Japanese infants : 1. Clinical and serological data from 25 patients. Pediatrics 17 : 349-358, 1956.

• 11) Plummer G : Anomalies occurring in children exposed in utero to the atomic bomb in Hiroshima. Pediatrics., 10 : 687-693, 1952.

• 12) Yamazaki JN, Wright SW, Wright PM : Outcome of pregnancy in women exposed to the atomic bomb in Nagasaki. Am. J. Dis. Child., 87 : 448-463, 1954.

• 13) Otake M. Schull WJ : Mental retardation in children exposed in utero to the atomic bombs : A reassessment. Lancet, in press.

• 14) Folley JH, Borges W, Yamawaki T : Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am. J. Med., 13 : 11-21, 1952.

• 15) Kato H, Brown CC, Hoel DG, et al : Studies of the mortality of A-bomb survivors-Report 7, Mortality, 1950-78 : Pt II. Mortality from causes other than cancer. Rad Res, in press.

• 16) Yamamoto T, Moriyama IM, Asano M, et al : Radiation Effects Research Foundation Pathology Studies, Hiroshima and Nagasaki, Report 4 ; The Autopsy Program and the Life Span Study, January 1961-December 1975, Radiation Effects Research Foundation. Technical. Report., 18-78, 1978.

• 17) Ichimaru M, Ishimaru T, Mikami M, et al : Incidence of leukemia in atomic bomb survivors and their controls in a fixed cohort, Hiroshima and Nagasaki, October 1950-December 1978. Radiation Effects Research Foundation. Technical. Report., 13-81, 1981.

• 18) Kato H, Schull WJ : Studies of the mortality of A-bomb survivors-Report 7, Mortality, 1950-1978 : Pt I. Cancer mortality, Rad Res, in press.

• 19) Wood JW, Tamagaki H, Neriishi S, et al : Thyroid carcinoma in atomic bomb survivors, Hiroshima-Nagasaki. Am. J. Epidemiol., 89 : 4-14, 1969.
  pubmed

• 20) Parker LN, Belsky JL, Yamamoto T, et al : Thyroid carcinoma diagnosed between 13 and 26 years after exposure to atomic radiation : A survey of the ABCC-JNIH Adult Health Study Program, Hiroshima and Nagasaki, 1958-71, Ann. Intern. Med., 8 : 600-604, 1974.

• 21) Wakabayashi T, Kato H, Ikeda T, et al : Studies of the mortality of A-bomb survivors-Report 7, Pt III. Incidence of cancer in 1959-1978, based on the Tumor Registry, Nagasaki, Rad Res. in press.

• 22) Tokunaga M, Norman JE Jr. Asano M, et al : Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74, JNCI 62 : 1348-1359, 1979.

• 23) McGregor DH, Land CE, Choi K, et al : Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69., JNCI 59 : 799-811, 1977.

• 24) Milton RC, Shohoji T : Tentative 1965 radiation dose estimation for atomic bomb survivors, Hiroshima-Nagasaki. Atomic Bomb Casualty Commission. Technical. Report., 1-68, 1968.

• 25) Kerr GD : Review of the dosimetry for the atomic bomb survivors, in Proceedings of the Fourth Symposium on Neutron Dosimetry, Gesellschaft fur Strahlen und Umweltforschung, Munich-Neuherberg, Germany, June 1-5, 1981. Luxembourg, Office for Official Publications of the European Communities. vol. 1, 1981, pp. 501-513.

• 26) Loewe WE, Mendelsohn E : Neutron and gamma doses at Hiroshima and Nagasaki, Lawrence Livermore Laboratory Publ UCRL-86595, 1981.

P.26 掲載の参考文献

• 1) Conard RA, Paglia DE, Larsen PR. et al : Review of medical findings in a Marshallese population twenty-six years after accidental exposure to radioactive fallout, Brookhaven National Laboratory report BNL 51261. Upton, NY, Brookhaven National Laboratory. January, 1980.

• 2) Conard RA, Knudson K, Sutow WW, et al : A twenty-year review of medical findings in a Marshallese population accidentally exposed to radioactive fallout, Brookhaven National Laboratory report BNL 50424. Upton, NY, Brookhaven National Laboratory. 1975.

• 3) Conard RA, Sutow WW, Dobyns BM, et al : Medical survey of the people of Rongelap and Utirik Islands thirteen, fourteen, and fifteen years after exposure to fallout radiation (March 1967, March 1968, and March 1969), Brookhaven National Laboratory report BNL 50220 (T-562). Upton, NY, Brookhaven National Laboratory. June, 1970.

• 4) Conard RA : A case of acute myelogenous leukemia following fallout radiation exposure. JAMA 232 : 1356-1357, 1975.

• 5) Larsen PR, Conard RA, Knudson K, et al : Thyroid hypofunction after exposure to fallout from a hydrogen bomb explosion. JAMA 247 : 1571-1575. 1982.

• 6) Sutow WW, Conard RA, Griffith KM : Growth status of children exposed to fallout radiation on Marshall Islands. Pediatrics., 36 : 721-731, 1965.
  pubmed

• 7) Conard RA, Rall JE, Sutow WW : Thyroid nodules as a late sequela of radioactive fallout in a Marshall Islands population exposed in 1954. N. Engl. J. Med., 274 : 1392-1399, 1966.

• 8) Sutow WW, Conard RA : The effects of fallout radiation on Marshallese children, in Sikov MR, Mahlum DD (eds) : Radiation Biology of the Fetal and Juvenile Mammal, Proceedings of the 9th Annual Hanford Biology Symposium, Richland, Wash, May 1969, CONF-690501, 1969, pp. 661-673.

• 9) Conard RA, Sutow WW, Colcock BP. et al : Thyroid nodules as a late effect of exposure to fallout, in Radiation-Induced Cancer, Proceedings of the IAEA Symposium, Athens, April 1969. Vienna, IAEA, 1969, pp. 325-336.

• 10) Stewart TD : Hrdlicka's Practical Anthropometry. Philadelphia, Wistar Institute, 1974, p. 230.

• 11) Garn SM, Sharmir A : Methods for Research in Human Growth. Springfield, III, Charles C Thomas, 1958, p. 121.

• 12) Bayer LM, Bayley N : Growth Diagnosis. Chicago, University of Chicago Press, 1959, p. 241.

• 13) Greulich WW, Dorfman RI, Catchpole HR. et al : Somatic and Endocrine Studies of Puberal and Adolescent Boys. Washington, DC, Sociological Research in Child Development, National Research Council, 1942, p. 85.

• 14) Greulich WW, Pyle SI : Radiographic Atlas of Skeletal Development of Hand and Wrist, ed 2, Stanford, Calif, Stanford University Press, 1959, p. 256.

• 15) Reynolds EL, Wines JV : Individual differences in physical changes associated with adolescence in girls. Am. J. Dis. Child., 75 : 329, 1948.

• 16) Reynolds EL, Wines JV : Physical changes associated with adolescence in boys. Am. J. Dis. Child., 82 : 529, 1951.

• 17) Shuttleworth FK : The Adolescent Period : A Pictorial Atlas, Monographs Sociological Research Child Development, Vol 15, No. 50. Evanston, III, Child Development Publications, 1951.

• 18) Belsky JL, Blot WJ : Adult stature in relation to childhood exposure to the atomic bombs in Hiroshima and Nagasaki. AJPH 65 : 489-94, 1975.

• 19) David J, Sobel EH : Validity of stature prediction near maturity. J. Pediatr., 95 : 992-993, 1979.

P.32 掲載の参考文献

• 1) Laster WR Jr. Mayo JG, Simpson-Herren L : Success and failure in the treatment of solid tumors : II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755. Cancer Chemother. Rep., 53 : 169, 1969.

• 2) Skipper HE, Schabel FM Jr. Wilcox WS : Experimental evaluation of potential anticancer agents : III. On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother. Rep., 35 : 1, 1964.

• 3) Lee ES : Osteosarcoma : A reconnaissance. Clin. Radiol., 26 : 5-25, 1975.
  pubmed

• 4) Sullivan MP, Sutow WW, Taylor G : L-phenylalanine mustard as a treatment for metastatic osteogenic sarcoma in children. J. Pediatr., 63 : 227-237, 1963.

• 5) Sutow WW, Sullivan MP, Fernbach DJ, et al : Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Cancer. 36 : 1598-1602, 1975.
  pubmed

• 6) Sutow WW, Sullivan MP, Wilbur JR. et al : Study of adjuvant chemotherapy in osteogenic sarcoma. J. Clin. Pharmacol., 15 : 530-553, 1975.
  pubmed

• 7) Wilbur JR, Sutcw WW, Sullivan MP. et al : Successful treatment of rhabdomyosarcoma with combination chemotherapy and radiotherapy. Proc. ASCO., 7 : 56, 1971.

• 8) Sutow WW : Chemotherapeutic management of childhood rhabdomyosarcoma, in Neoplasia in Childhood. Chicago, Year Book Medical Publishers, 1969, pp. 201-208.

• 9) Pinkel D : Cyclophosphamide in children with cancer. Cancer 15 : 42, 1962.
  pubmed

• 10) Finkelstein J, Hittle RE, Hammond GD : Evaluation of a high dose of cyclophosphamide regimen in childhood tumors. Cancer 23 : 1239, 1969.

• 11) Friedman MA, Carter SK : The therapy of osteogenic sarcoma : Current status and thoughts for the future. J. Surg. Oncol., 4 (5/6) : 482, 1972.

• 12) Cortes EP, Holland JE, Wang JJ. et al : Chemotherapy of advanced osteosarcoma, in Proceedings of the 24th Symposium of the Colston Research Society. London, Butterworth, 1972.

• 13) Sutow WW, Sullivan MP, Wilbur JR. et al : L-phenylalanine mustard (NSC-8806) administration in osteogenic sarcoma : An evaluation of dosage schedules. Cancer Chemother. Rep., 55 : 151-157, 1971.
  pubmed

• 14) Sutow WW : Combination chemotherapy with adriamycin (NSC-123127) in primary treatment of osteogenic sarcoma (part 3). Cancer Chemother. Rep., 6 : 315-317, 1975.

• 15) Sutow WW, Gehan EA, Vietti TJ. et al : Multidrug chemotherapy in primary treatment of osteosarcoma. J. Bone. Joint. Surg., 58-A : 629-633, 1976.

• 16) Sutow WW, Gehan EA, Dyment PG. et al : Multidrug adjuvant chemotherapy in osteosarcoma : Interim report of the Southwest Oncology Group studies. Cancer Treat. Rep., 62 (2) : 265-269, 1978.

• 17) Jaffe N : Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 : 1627-1631, 1972.
  pubmed

• 18) Wang YM, Lantin E, Sutow WW : Blood, urinary, and cerebrospinal fluid methotrexate levels in children after high dose methotrexate infusion. Clin. Chem., 22 : 1053-1056, 1976.

• 19) Wang YM, Kim P-Y, van Eys J. et al : Study of contaminants and metabolites during therapy with high doses of methotrexate. Clin. Chem., 20 : 1937, 1976.

• 20) Wang YM, Kim PY, Lantin E. et al : Degradation and clearance of methotrexate in children with osteosarcoma receiving high dose infusion. Med Pediatr. Oncol 4 : 221-229, 1978.
  pubmed

• 21) Perez C, Wang YM, Sutow WW. et al : Significance of 48-hour plasma level in high-dose methotrexate regimens. Cancer. Clin. Trials., 1 : 107-111, 1978.
  pubmed

• 22) Wang YM, Sutow WW, Romsdahl MM. et al : Age related pharmacokinetics of high dose methotrexate in patients with osteosarcoma. Cancer Treat. Rep., 63 : 405-410, 1979.
  pubmed

• 23) Perez C, Sutow WW, Wang YM. et al : Evaluation of overall toxicity of high-dosage methotrexate regimens. Med. Pediatr. Oncol., 6 : 219-228, 1979.
  pubmed

• 24) Rosen G, Caparros B, Huvos AG. et al : Preoperative chemotherapy for osteosarcoma : Selection of postoperative adjuvant treatment based on the response of the primary tumor to preoperative chemotherapy. Cancer 49 : 1221-1230, 1982.
  pubmed

• 25) Jaffe N, Link M, Traggis D. et al : The role of high dose methotrexate in osteogenic sarcoma : Sarcomas of soft tissue and bone in childhood. NCI. Monogr., 56 : 201-206, 1981.

• 26) Jaffe N, Watts H, Fellows KE. et al : Local en bloc resection for limb preservation. Cancer Treat. Rep., 62 : 217-223, 1978.
  pubmed

• 27) de Santos LA, Murray JA, Ayala AG : The value of percutaneous needle biopsy in the management of primary bone tumors. Cancer 43 : 735, 1979.
  pubmed

• 28) Herson J, Sutow WW, Elder K. et al : Adjuvant chemotherapy in nonmetastatic osteosarcoma : A Southwest Oncology Group Study. Med Pediatr. Oncol., 8 : 343-352, 1980.

• 29) Jaffe N, Frei E III, Smith E, et al : A hypothesis for the pattern of pulmonary metastases in osteogenic sarcoma : Impact of adjuvant therapy. Proc. AACR/ASCO., 19 : 400, 1978.

• 30) Sutow WW : Late metastases in osteosarcoma. Lancet 1 : 856, 1976.
  pubmed

• 31) Sutow WW, Herson J, Perez C : Survival after metastasis in osteosarcoma. JNCI. Monogr., 56 : 227-231, 1981.

• 32) Perez C, Herson J, Kimball JC. et al : Prognosis after metastases in osteosarcoma. Cancer Clin. Trials., 1 : 315-320, 1978.
  pubmed

• 33) Kolata GB : Dilemma in cancer treatment. Science 209 : 792-794, 1980.
  pubmed

• 34) Brostrom LA, Apairsi T, Ingimarsson SN. et al : Can historical controls be used in current clinical trials in osteosarcoma? Metastasis and survival in a historical and a concurrent group. Int. Radiat. Oncol. Biol. Phys., 6 : 1717-1721, 1980.

• 35) Edmonson JH, Green SJ, Ivins JC. et al : Methotrexate as adjuvant treatment for primary osteosarcoma. N. Engl. Med., 303 : 642-645, 1980.
  pubmed

• 36) Gehan EA, Sutow WW : Evaluation of results of new treatment for osteosarcoma. Int. J. Radiat. Oncol. Biol. Phys., 6 : 1757-1758, 1980.
  pubmed

• 37) Uribe-Botero G, Russell WO, Sutow WW. et al : Primary osteosarcoma of bone : A clinicopathologic investigation of 243 cases with necropsy studies in 54. Am. J. Clin. Pathol., 67 : 427-435, 1977.

• 38) Gehan EA, Sutow WW, Uribe-Botero G, et al : Osteosarcoma : The M. D. Anderson experience, 1950-1974, in Terry WD, Windhorst D (eds) : Immunotherapy of Cancer : Present Status of Treatment in Man. New York, Raven Press, 1978, pp. 271-282

P.41 掲載の参考文献

• 1) Jaffe N : Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 : 1627-1631, 1972.
  pubmed

• 2) Jaffe N, Frei, E III, Traggis. D., et al : Adjuvant methotrexate and citrovorum treatment of osteogenic sarcoma. N. Engl. J. Med., 291 : 994-998, 1974.

• 3) Cortes EP, Holland JF, Wang, J.J., et al : Amputation and adriamycin in primary osteosarcoma. N. Engl. J. Med., 291 : 998-1000, 1974.
  pubmed

• 4) Sutow WW, Sullivan MP, Wilbur JR, et al : Study of adjuvant chemotherapy in osteogenic sarcoma. J. Clin. Pharmacol., 7 : 530-533, 1975.
  pubmed

• 5) Pratt CB : Chemotherapy of osteosarcoma : An overview, in Van Oosterom AT, Muggia FM, Cleton FJ (eds) : Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas. The Hague, Martinus Nijhoff Publishers, 1980, pp. 329-348.

• 6) Sutow WW, Gehan EA. Dyment PA, et al : Multidrug adjuvant chemotherapy for osteosarcoma : Interim report of the Southwest Oncology Group Studies. Cancer Treat. Rep., 62 : 265-270, 1978.

• 7) Marcove RC, Rosen G : En bloc resections for osteogenic sarcoma. Cancer 45 : 3040-3044, 1980.
  pubmed

• 8) Rosen G, Huvos AG, Nirenberg A. et al : Osteogenic sarcoma (OSA) : Selection of adjuvant chemotherapy (CT) based upon the response of the primary tumor to preoperative (PreO) CT. Proc. AACR/ASCO 22 : 429, 1981.

• 9) Pratt CB, Evans WE, Kumar, APM. et al : Osteosarcoma (OS)-outcome of therapy for 100 patients at St. Jude Children's Research Hospital 1973-1980. Proc. AACR/ASCO, 22 : 428, 1981.

• 10) Price CHG, Jeffree GM : Metastatic spread of osteosarcoma. Brit. J. Cancer., 28 : 515-524, 1973.

• 11) Jeffree G.M, Price, CHG, Sissons, H.A : The metastatic patterns of osteosar coma. Brit. J. Cancer., 32 : 87-107, 1975.

• 12) Kumar APM, Wrenn E. L Jr, Fleming I.D. et al : Transmedullary amputation and resection of metastases in combined therapy of osteosarcoma. J. Pediatr. Surg., 12 : 427-435, 1977.

• 13) Jaffe N, Frei III, Smith E. et al : A hypothesis for the pattern of pulmonary metastases in osteogenic sarcoma : Impact of adjuvant chemotherapy. Proc. AACR/ASCO., 19 : 400, 1978.

• 14) Rosen G, Huvos AG, Mosende C. et al : Chemotherapy and thoracotomy for metastatic osteogenic sarcoma : A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 4 : 841-849, 1978.

• 15) Giritsky AK, Etcubanas E, Mark JBD : Pulmonary resection in children with metastatic osteogenic sarcoma. J. Thorac. Cardiovasc. Surg., 75 : 354-362, 1978.

• 16) Telander RL, Pairolero PC, Pritchard DJ. et al : Resection of pulmonary metastatic osteogenic sarcoma in children. Surgery 84 : 335-341, 1978.
  pubmed

• 17) Rosenberg SA, Flye MW, Conkle D. et al : Treatment of osteogenic sarcoma : II. Aggressive resection of pulmonary metastases. Cancer Treat. Rep., 63 : 753-756, 1979.

• 18) McKillop JH, Etcubanas E, Goris ML : The indications for and limitations of bone scintigraphy in osteogenic sarcoma : A review of 55 patients. Cancer 48 : 1133-1138, 1981.
  pubmed

• 19) Kreet L : Computerized tomography using the EMI general purpose scanners. Brit. J. Radiol., 50 : 2-14, 1977.

• 20) Herman G, Rose JS : Computed tomography in bone and soft tissue pathology of the extremities. J. Comput. Assist. Tomogr., 3 : 58-66, 1979.

• 21) Kolata GB : Dilemma in cancer treatment. Science 209 : 792-794, 1980.
  pubmed

P.51 掲載の参考文献

• 1) D'Angio GJ, Beckwith JB, Breslow NE. et al : Wilms' tumor : An update. Cancer 45 : 1791-1798, 1980.

• 2) Sutow WW, Gehan EA, Heyn RM. et al : Comparison of survival curves, 1956 versus 1962, in children with Wilm's tumor and neuroblastoma. Pediatrics, 45 : 800-811, 1970.
  pubmed

• 3) Byrd RL, Evans AE, D'Angio GJ : Adult Wilms' tumor effects of combined therapy on survival. J Urol, in press.

• 4) Raney RB Jr, Palmer N, Sutow WW. et al : Renal cell carcinoma in children. Pediatr Surg, in press.

• 5) Lemerle J, Voute PA, Tournade MF. et al : Effectiveness of preoperative chemotherapy in Wilms' tumor : Results of a clinical trial conducted by the International Society of Pediatric Oncology (SIOP), in Raybaud C, Clement R, Lebreuil G. et al : (eds) : Proceedings of the XIIIth Meeting of SIOP, International Congress Series 570. Amsterdam, Excerpta Medica, 1982.

• 6) D'Angio GJ, Evans A, Breslow N. et al : The treatment of Wilms' tumor : Results of the second National Wilms' Tumor Study. Cancer 47 : 2302-2311, 1981.
  pubmed

P.56 掲載の参考文献

• 1) Sutow WW, Sullivan MP, Reid HL. et al : Prognosis in childhood rhabdomyosarcoma. Cancer 25 : 1384, 1970.

• 2) Maurer HM, Moon T, Donaldson M. et al : The Intergroup Rhabdomyosarcoma Study : A preliminary report. Cancer 40 : 2015-2026, 1977.
  pubmed

• 3) Maurer HM (for the IRS Committee) : The Intergroup Rhabdomyosarcoma Study II : Objectives and study design. J. Pediatr. Surg., 15 : 371, 1980.

• 4) Lawrence W, Jegge G, Foote FW : Embryonal rhabdomyosarcoma, a clinicopathological study. Cancer 17 : 361, 1964.
  pubmed

• 5) Maurer HM, Donaldson M, Gehan EA. et al : The Intergroup Rhabdomyosarcoma Study : Update-November, 1978. Natl. Cancer. Inst. Monogr., 56 : 61-68, 1981.

• 6) Gehan EA, Glover FN, Maurer HM. et al : (for the IRS Committee) : Prognostic factors in children with rhabdomyosarcoma. Natl. Cancer. Inst. Monogr., 56 : 83-92, 1981.

• 7) Lawrence W, Hays DM, Moon TE (for the IRS Committee) : Lymphatic metastasis with childhood rhabdomyosarcoma. Cancer 39 : 556-559, 1977.

• 8) Raney RB, Hays DM, Lawrence W. et al : (for the IRS Committee) : Paratesticular rhabdomyosarcoma in childhood. Cancer 42 : 729-736, 1978.

• 9) Hays DM, Soule EH, Lawrence W. et al : (for the IRS Committee) : Extremity lesions in the Intergroup Rhabdomyosarcoma Study (IRS-II) : A preliminary report. Cancer 48 : 1-8, 1982.

• 10) Tefft M, Fernandez C, Donaldson M. et al : Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children : A report of the Intergroup Rhabdomyosarcoma Study (IRS). Cancer 42 : 253-258, 1978.
  pubmed

• 11) Gaiger AM, Soule EH, Newton WA Jr (for the IRS Committee) : Pathology of a rhabdomyosarcoma experience of the Intergroup Rhabdomyosarcoma Study, 1972-1978. Natl. Cancer. Inst. Monogr., 56 : 19-27, 1981.

• 12) Hays D, Newton W Jr, Soule E. et al : (for the IRS Committee) : Influence of alveolar histology on survival in the Intergroup Rhabdomyosarcoma Study (IRS-I). ASCO Meeting, St. Louis, April, 25-27, 1982.

• 13) Raney RB, Crist WM, Maurer HM. et al : (for the IRS Committee) : Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response : A report from the Intergroup Rhabdomyosarcoma Study. Cancer in press.

• 14) Sutow WW, Foulkes MA, Heyn RM. et al : Risk of late relapse after disease-free survival (DFS) of 2 years in children with rhabdomyosarcoma (RMS) : Report from the Intergroup Rhabdomyosarcoma Study (IRS). ACCR Meeting, Washington, DC, April, 29, 1981.

• 15) Crist W, Raney B, Newton W. et al : (for the IRS Committee) : Intrathoracic soft tissue sarcomas in children. Cancer, in press.

• 16) Ruymann FB, Newton WA Jr, Ragab A. et al : (for the IRS Committee) : Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma : A report from the Intergroup Rhabdomyosarcoma Study. Cancer (in press).

• 17) Sutow WW, Lindberg RD, Gehan EA. et al : Three-year relapse-free survival rates in childhood rhabdomyosarcoma of the head and neck : Report of the Intergroup Rhabdomyosarcoma Study. Cancer (in press).

• 18) Raney RB Jr, Tefft M, Maurer HM. et al : (for the IRS Committee of the CCSG and POG) Results of intensive treatment of children with cranial parameningeal sarcoma : A report from the Intergroup Rhabdomyosarcoma Study (IRS). AACR Meeting, St. Louis, April, 28-May 1, 1982.

• 19) Hays DM, Raney RB, Lawrence W. et al. (for the IRS Committee) : Bladder and prostatic tumors in the Intergroup Rhabdomyosarcoma Study (IRS-I) : Preliminary results of therapy. Cancer (in press).

• 20) Hays D, Raney RB, Lawrence W. et al. (for the IRS Committee) : Rhabdomyosarcoma of the female genitourinary tract. J. Pediatr. Surg., 16 : 828-834, 1981.

• 21) Raney RB Jr, Hays D, Maurer HM, et al : Ireatment of childrenye with localized sarcoma of the prostate, bladder, and vagina by primary chemotherapy, followed by surgery and/or radiotherapy (RT) : Preliminary results of the Intergroup Rhabdomyosarcoma Study (IRS-II). ASCO Meeting, St. Louis, April, 25-27, 1982.
  pubmed

• 22) Tefft M, Lindberg R, Gehan E (for the IRS Committee) : Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children : Local control in patients enrolled into the Intergroup Rhabdomyosarcoma Study (IRS), Natl. Cancer. Inst. Monogr., 56 : 75-81, 1981.

P.60 掲載の参考文献

• 1) Conard RA, Paglia DE, Larsen PR. et al : Review of medical findings in a Marshallese population twenty-six years after accidental exposure to radioactive fallout, Brookhaven National Laboratory report BNL 51261. Upton, NY, Brookhaven National Laboratory, January 1980.

• 2) Suto WW, Vietti TJ, Fernbach DJ (eds) : Clinical Pediatric Oncology. St. Louis, CV Mosby Co. 1977.

• 3) Miller RW : Highlights in clinical discoveries relating to ataxia-telangiectasia, in Bridges BA, Hamden DG (eds) : Ataxia-telangiectasia A Cellular and Molecular Link Between Cancer, Neuropathology and Immune Deficiency. Sussex. England, John Wiley and Sons. Ltd, 1982.

• 4) Miller RW : The discovery of human teratogens, carcinogens, and mutagens : Lessons for the future, in Hollaender A, de Serres FJ (eds) : Chemical Mutagens, 1978, vol. 5, pp. 101-126.

• 5) Klein G, Purtilo DT (eds) : Symposium on Epstein-Bar virus induced lymphoproliferative diseases in immunodeficient patients. Cancer Res., 41 : 4209-4304, 1981.

• 6) Purtilo DT, Cassel C, Yang JPS. et al : X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1 : 935-941, 1975. Purtilo, DT. : Pathogenesis and phenotypes of an X-linked lymphoproliferative syndrome. Lancet 2 : 882-885, 1976.

• 7) Miller RW : Deaths from childhood leukemia and solid tumors among twins and other sibs in the United States, 1960-1967. JNCI 46 : 203-209, 1971.

• 8) Kassan SS, Thomas TT. et al : Increased risk of lymphoma in sicca syndrome. Ann. Intern. Med. 89 : 888-892, 1978.

• 9) Riccardi VM, Sujansky E, Smith AC. et al : Chromosomal imbalance in the aniridia-Wilms' tumor association : 11p interstitial deletion. Pediatrics 61 : 604-610, 1978.
  pubmed

P.70 掲載の参考文献

• 1) Bull JP : The historical development of clinical therapeutic trials. J. Chron. Dis., 10 : 218-248, 1959.
  pubmed

• 2) Fisher RA : Statistical Methods of Research Workers, ed 13. New York, Hafter, 1958.

• 3) Hill AB : Principles of Medical Statistics, ed 8. New York, Oxford University Press, 1966.

• 4) Wald A : Sequential Analysis. New York, John Wiley and Sons, 1947.

• 5) Hippocrates : Precepts, WHS Jones (trans). London, Wm. Heinemann, 1923.

• 6) Crombie AC : In Wickens GM (ed) : Avicenna, Scientist and Philosopher. London, Luzac & Company, Ltd, 1952, p.89.

• 7) Bacon R : De erroribus medicorum, ET Witherington (trans), in Essays on the History of Medicine Presented to Karl Sudhoff, London, Oxford University Press, 1924, p. 139, c1268.

• 8) National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research : The Belmont Report : Ethical Principles and Guidelines for the Protection of Human Subjects of Research, DHEW Publication Number 78-0012, 1978.

• 9) Packard FR : The Life and Times of Ambroise Pare, ed 2. New York, Paul B. Hoeber, Inc, 1925.

• 10) Lind J : A Treatise of the Scurvy. Edinburgh, Sands, Murray & Cochran, 1753.

• 11) Maitland C : Account of Inoculating the Small Pox. London, J. Roberts, 1722.

• 12) Jenner E : An Inquiry Into the Causes and Effects of the Variolae Vaccinae. London, S. Low, 1798.

• 13) Fibiger J : Om Serumbehandlung of Difteri. Hospitalstidende 4(6) : 309, 337, 1898.

• 14) International Cancer Research Data Bank : Compilation of Experimental Cancer Therapy Protocol Summaries, ed 5. NIH Publication Number 81-1116, 1981.

• 15) Cobbett W : The Rush Light. New York, Wm. Cobbett, 1800.

• 16) Louis PCA : Essay of Clinical Instruction, P. Martin (trans). London, S. Highley, 1834, pp. 26, 27, 28.

• 17) Armitage P : Sequential Medical Trials, ed 2. New York, John Wiley and Sons, 1975.

• 18) Simone JV : Childhood leukemia as a model for cancer research : The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res., 10 : 218-248, 1959.

• 19) National Center for Health Statistics : Annual Summary of Births, Deaths, Marriages and Divorces : United States, 1980.

• 20) Young JL, Percy CL, Asere AJ (eds) : Surveillance, Epidemiology, and End Results : Incidence and Mortality Data, 1973-1977, NCI Monograph Number 57, June, 1981.

• 21) Bennett JH : Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood. Edinburgh. Med. SJ., 64 : 413-423, 1845.

• 22) Southan CM, Craver LF, Dargeon HW. et al : A study of the natural history of acute leukemia with special reference to the duration of the disease and the recurrence of remiss ons. Cancer 4 : 39-59, 1951.

• 23) Tivey H : The natural history of untreated acute leukemia. Ann. Ny. Acad. Sci., 60 : 322-358, 1954.
  pubmed

• 24) Farber S, Diamond LK, Mercer RD. et al : Temporary remissions ill acute leukemia in children producedby folic acid antagonist 4-aminopteroly-glutamic acid, aminopterin. N. Engl. J. Med., 238 : 787-793, 1948.

• 25) Frei E, Holland JE, Schneiderman MA. et al : A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood 12 : 1126-1148, 1958.

• 26) Frei E, Freireich EJ : Progress and Perspectives ill the Chemotherapy of Acute Leukemia, vol 2, Advances ill Chemotherapy. New York, Academic Press, 1965, pp. 269-293.

• 27) Simone J : The treatment of acute lymphoblastic leukemia. Brit. J. Haematol., 45 : 1-4, 1980.

• 28) Skipper HE, Schabel FM, Wilcox WS : Experimental evaluation of potential anticancer a gents : XII. On the criteria and kinetics associated with "curability" of experimental leukemia. Cancer Chemother. Rep., 35 : 1-111, 1964.

• 29) Aur RJA. Simone J, Hustu HO. et al : Central nervous system therapy and combination chemotheraphy in childhood lymphoblastic leukemia. Blood 37 : 272-281, 1971.

• 30) Mauer A M : Therapy of acute lymphoblastic leukemia in childhood. Blood 56 : 1-10, 1980.
  pubmed

• 31) George SL, Aur RJA, Mauer AM. et at : Areappraisal of the results of stopping therapy in childhood leukemia. N. Engl. J. Med., 300 : 269-274, 1979.

• 32) George SL : Design and evaluation of leukemia trials. Clin Haematol 7 : 227-243, 1978.
  pubmed

• 33) George SL : Statistical design for pediatrics : Past, present and future, In van Eys J, Sullivan MP (eds) : Status of the Curability of Chidhood Cancers. New York, Raven Press, 1980, pp. 47-59.

P.78 掲載の参考文献

• 1) D'Angio GJ : Perspectives of pediatric oncology-battlegrounds old and new,in Proceedings of the National Conference on the Care of the Child with Cancer. New York, American Cancer Society, 1979, pp. 1-6.

• 2) Frei E, Holland JF, Schneiderman MF, et al : A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood 13 : 1126-1148, 1958.

• 3) Heyn RM, Brubaker CA, Burchenal JM. et al : The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children : Results of a cooperative study. Blood 15 : 350-359, 1960.

• 4) Johnston DA : Analysis of clinical trials. Cancer Bull., 32 : 216-221, 1980.

• 5) Hammond D, Chard RL, D'Angio GJ. et al : Pediatric malignancies in Hoogstraaten B(ed) : Cancer Research, Impact of the Cooperative Groups. New York, Masson Publishing USA, Inc, 1980, pp. 1-23.

• 6) van Eys J, Sullivan, MP (eds) : The Status of the Curability of Childhood Cancers New York, Raven Press, 1980.

• 7) van Eys J : Childhood lymphocytic leukemia : Definition of the disease. Cancer Bull., 30 : 169-177, 1978.

• 8) Pullen JD, Falletta JM, Crist WM. et al : Southwest Oncology Group experience with immunologic phenotyping in acute lymphocytic leukemia. Cancer Res., 41 : 4802-4809, 1981.

• 9) Roper M, Crist W, Ragab A. et al : for POG : Pre-B cell leukemia differs in its response to therapy, abstract #512. Blood 58 : 150a, 1981.

P.84 掲載の参考文献

• 1) Perez C, Wang YM, Sutow WW. et al : Significance of the 48-hour plasma level in high-dose Methotrexate regimens. Cancer. Clin. Trials., 1 : 107-111, 1978.
  pubmed

• 2) Wang YM, Lantin E, Sutow WW. Methotrexate in blood, urine and cerebrospinal fluid of children receiving high dose by infusion. Clin. Chem., 22 : 1053-1056, 1976.

• 3) Wang YM, Sutow WW, Romsdahl MM. et al : Age related pharmacokinetics of high dose Methotrexate in patients with osteosarcoma. Cancer Treat. Rep., 63 : 405-410, 1979.
  pubmed

• 4) Wang YM, Sasaki K, Sun AD. et al : The clinical pharmacology of high dose Methotrexate, in Kimura KK, Sutow WW, Wang YM (eds) : Methotrexate and Cancer Therapy. New York, Raven Press, in press.

• 5) Wang YM : The contribution of clinical pharmacology in the treatment of childhood cancer. Cancer Chemother., 8 : 54-63, 1981.

P.88 掲載の参考文献

• 1) Miller RW : Prevention-the ultimate solution, in van Eys J, Sullivan MP (eds) : Status of the Curability of Childhood Cancers. New York, Raven Press, 1980, pp. 307-314.

• 2) Newell GR : Etiology of multiple sclerosis and Hodgkin's disease. Am. J. Epidemiol., 91 : 119-122, 1970.
  pubmed

• 3) Gutensohn N, Cole P : Epidemiology of Hodgkin's disease in the young. Int. J. Cancer, 19 : 595-604, 1977.

• 4) Lober M, Rawlings W, Newell GR. et al : Sinus histiocytosis with massive lymphadenopathy : Report of a case associated with elevated EBV antibody titers. Cancer 32 : 421-425, 1973.
  pubmed

• 5) Jensen RD, Miller RW : Retinoblastoma : Epidemiologic characteristics. N. Engl. J. Med., 285 : 307-311, 1971.
  pubmed

• 6) Newell GR, Roberts JD, Baranovsky A : Retinoblastoma : Presentation and survival in Negro children compared with whites. JNCI 49 : 989-992, 1972.
  pubmed

• 7) Axtell LM, Asire AJ, Myers MH : Cancer Patient Survival report 5, End Results Section, Biometry Branch, Division of Cancer Cause and Prevention, National Cancer Institute. Washington, DC, Government Printing Office, 1976.

• 8) Newell GR : Measuring improved survival in cancer patients. Cancer 25 : 338-343, 1975.
  pubmed

P.102 掲載の参考文献

• 1) 藤本孟男, W.W. Sutow : 広汎転移後の小児悪性固形腫瘍の長期生存. 癌の臨床 23 : 1011-1016, 1977.

• 2) Burkitt, D. : A sarcoma involving the jaw in African children. Brit. J. Surg., 46 : 218-223, 1958.
  pubmed

• 3) Burkitt, D., Hutt, M.S.R., Wright, D.H. : The African lymphoma. Preliminary observations on response to therapy. Cancer 18 : 399-410, 1965.

• 4) Ziegler, J.L., Morrow, R.H., Fas. L. et al : Treatment of Burkitt's tumor with cyclophosphamide. Cancer 26 : 474-484, 1970.

• 5) Ziegler, J.L., Magrath, I.T., Olweny, C.L.M. : Long survival of Burkitt's Lymphomd in Uganda. Proc. Am. Soc. Clin. Oncol., 20 : 430,1979 (abstract).

• 6) Burchenal, J.H. : Long Term Remissions in Acute Leukemia in Chemotherapy of Cancer Plattner P. A. (ed). Amsterdam, Elsevier, 1964, pp. 257-262.

• 7) Pinkel, D. : Cure of the child with cancer : Definition and prospective, In Care of the Child with Cancer. American Cancer Society, New York. pp. 191-200.

• 8) Farber, S. : Chemotherapy in the treatment of leukemia and Wilm's tumor. JAMA 198 : 826-836, 1966.
  pubmed

• 9) Vietti, T.J., Sullivan, M.P. et al : Vincristine sulfate and radiation therapy in metastatic Wilm's tumor. Cancer 25 : 12-20, 1970.
  pubmed

• 10) Sutow, W.W. : Chemotherapeutic management of childhood rhabdomyosarcoma. Neoplasia in Childhood. pp. 201-208, Year Book Medical Publishers, Chicago 1969.

• 11) Jaffe, N. : Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 : 1627-1631, 1972.
  pubmed

• 12) Farber, S., D'Angio, G., Evans, A. et al : Clinical studies of actinomycin D with special reference to Wilms' tumor in children. Ann. N. Y. Acad. Sci., 89 : 421-425, 1960.

• 13) Sutow, W.W., Sullivan, M. P., Frenbach, D.J. et al : Adjuvant chemotherapy in primary treatment of osteogenic sarcoma. Cancer 36 : 1598-1602, 1975.

• 14) Hammond, D., Bleyer, W.A., Hartman, J.R. et al : The team approach to the management of pediatric cancer. Cancer 41 : 29-35, 1978.

• 15) Fujimoto, T. : Treatment of acute childhood leukemia. Acta. Haematol. Jpn. 43 : 1041-1051, 1980.

• 16) Sutow, W.W. : Definitions and scopel. Status of the Curability of Childhood Cancers, edited by J. van Eys and M. P. Sullivan. Raven Press. New York, 1980, pp. 19.

• 17) Farber, S. : The control of cancer in children. Neoplasia in Childhood, pp. 321-327, Year Book Medical Publishers, Chicago 1969.

• 18) Sutow, W.W. : 強力な多種専門医のチーム治療による小児固形腫瘍制禦の成功. 癌と化学療法 5 : 1-6, 1978.

• 19) Fraumeni, J.F. Jr. : Persons at high risk of cancer. An approach to cancer etiology and control. New York/San Francisco/London, Academic Press, Inc. 1975, pp. 544.

• 20) Draper, G.J., Heat, M.M., Kinnie-Wilson, L.M. : Occurrence of childhood cancers among sibs and estimation of familial risks. J. Med. Genetics., 14 : 81-90, 1977.

• 21) Herbst, A.L., Ulfeldler, H., Poskanzer, D.C. : Adenocarcinoma of the vagina : Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med., 284 : 878-881, 1971.

• 22) Lynch, H.A., Lynch, P.M., Lynch, J.F. et al. : Familial cancer syndromes : A survey. Cancer 39 : 1867-1881, 1977.

• 23) D'Angio, G. : It Ain't Necessarily So. Status of the Curability of Childhood Cancers, edited by J. van Eys and M. P. Sullivan. Raven Press, New York, 1980, pp. 5-16.

• 24) Simpson-Herren, L., Sanford, A.H., Holmquist, J.P. : Cell population kinetics of transplanted and metastatic Lewis lung cancer. Cell. Tissue. Kinet., 7 : 349-361, 1974.
  pubmed

• 25) Schabel, F.M. Jr. : Surgical adjuvant chemotherapy of metastatic murine tumors. Cancer 40 : 558-568, 1977. Come Let us Now Praise This Famous Man in Memoriam Address given at the Memorial Services for Wataru W. Sutow, on December 27 and 28, 1981 in the Chapel of M. D. Anderson Hospital and Tumor Institute.

第II章 小児癌の進行例の治療管理と包括援助

P.137 掲載の参考文献

• 1) Nowell, P.C. and Hungerford, D.A. : A minute chromosome in human chronic granulocytic leukemia. Science 132 : 1497, 1960.

• 2) Rowley, J.D. : Chromosome changes in acute leukemia. Brit. J. Haematol., 44 : 339, 1980.

• 3) Rowley, J.D. : A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 243 : 290, 1973.
  pubmed

• 4) Fourth International Workshop on Chromosomes in Leukemia (1982) : Cancer Genet. Cytogenet., (in press).

• 5) Benedict, W.F., Lange, M., Greene, J., Derenscenyi, A. and Alfi, O.S. : Correlation between prognosis and bone marrow chromosomal patterns in children with acute nonlymphocytic leukemia : Similarities and differences compared to adults. Blood 54 : 818, 1979.
  pubmed

• 6) Morse, H., Hays, T., Rose, B. and Robinson, A. : Acute nonlymphoblasticle leukemia in childhood : High incidence of clonal abnormalities and nonrandom changes. Cancer 44 : 164, 1979.

• 7) Prigogina, E.L., Fleischman, E.W., Puchkova, G.P., Kulagina, O.E., Majakova, S.A., Balakirev, S.A., Frenkel, M.A., Khvatova, N.V. and Peterson, I.S. : Chromosomes in acute leukemia. Hum. Genet., 53 : 5, 1979.
  pubmed

• 8) Hagemeijer, A., Van Zanen, G.E., Smit, E.M.E. and Hahlen, K. : Bone marrow karyotypes of children with nonlymphocytic leukemia. Pediatr. Res., 13 : 1247, 1979.

• 9) Hagemeijer, A., Hahlen, K. and Abels, J. : Cytogenetic follow-up of patients with nonlymphocytic leukemia. II. Acute nonlymphocytic leukemia. Cancer Genet. Cytogenet., 3 : 109, 1981.
  pubmed

• 10) Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gramick, N.R. and Sultan, C. : French-American-British (FAB) Cooperative Group Proposals for the classification of the acute leukaemias. Brit. J. Haematol., 33 : 451, 1976.

• 11) An International System for Human Cytogenetic Nomenclature (1978) : Cytogenet. Cell Genet., 21 : 309, 1978.
  pubmed

• 12) Kaplan, E.L. and Meier, P. : Nonparametric estimation for incomplete observations. J. Am. Stat. Assoc., 53 : 457, 1958.

• 13) Gehan, E. : Ageneralized Wilcoxon test for comparing arbitrarily singly-censored samples. Biemetrika 52 : 203, 1965.

• 14) Sakurai, M. and Sandberg, A.A. : Prognosis of acute myeloblastic leukemia : Chromosomal correlation. Blood 41 : 93, 1973.
  pubmed

• 15) Yunis, J.J., Bloomfield, C.D. and Ensrud, K. : All patients with acute nonlymphocytic leukemia may have a chromosomal defect. N. Engl. J. Med., 305 : 135, 1981.
  pubmed

• 16) Kaneko, Y. and Sakurai, M : 15/17 translocation in acute promyelocytic leukaemia. Lancet 1 : 961, 1977.

• 17) Okada, M., Miyazaki, T. and Kumota, K. : 15/17 translocation in acute promyelocytic leukaemia. Lancet 1 : 961, 1977.

• 18) Sakurai, M.,Kaneko, Y. and Abe, R : Further characterization of acute myelogenous leukemia with t (8 ; 21) chromosome translocation. Cancer Genet. Cytogenet., 6 : 143, 1982.

• 19) Van den Berghe, H., Parloir, C., David, G., Michaux, J.L. and Sokal, G. : A new characteristic karyotypic anomaly in lymphoproliferative disorders. Cancer 44 : 188, 1979.
  pubmed

• 20) Kaneko, Y., Rowley, J.D., Maurer, H.S., Variakojis, D. and Moohr, J.W. : Chromosome pattern in childhood acute nonlymphocytic leukemia (ANLL). Blood 60 : 389, 1982.
  pubmed

• 21) Kaneko, Y., Rowley, J.D., Variakojis, D., Chilcote, R.R., Check, I. and Sakurai, M. : Correlation of karyotype with clinical features in acute lymphoblastic leukemia. Cancer Res., 42 : 2918, 1982.
  pubmed

• 22) Van den Berghe, H., David, G., Broeckaert-Van Orshoven, A., Louwagie, A., Verwilghen, R., Casteels-Van Daele, M., Eggermont, E. and Eeckels, R. : A new chromosome anomaly in acute lymphoblastic leukemia (ALL). Hum. Genet., 46 : 173, 1979.

• 23) Parkin, J.L., Arthur, D.C., Abramson, C.S., McKenna, R.W., Kersey, J.H., Heideman, R.L. and Brunning, R.D. : Acute leukemia associated with the t(4 ; 11) chromosome rearrangement : Ultrastructural and immunologic characteristics. Blood, 60 : 1321, 1982.

• 24) Bloomfield, C.D. and Arthur, D.C. : Del (16) (q21 or 22) and marrow eosinophilia in acute nonlymphoblastic leukemia (ANLL) : A new cytogenetic-clinical association. Am. Soc. Clin. Oncol., 23 : 191, 1982.

• 25) Larson, R.A., LeBeau, M.M., Bitter, M.A., Vardiman, J.W., Golomb, H.M. and Rowley, J.D. : Association of inv(16) (P13 q22) with marrow eosinophilia in acute myelomonocytic leukemia (AMMOL). Blood (Suppl.) 60 : 131a, 1982.

• 26) Kaneko, Y., Sakurai, M. and Hattori, M. : Childhood acute myelogenous leukemia with an 8-21 chromosome translocation. J. Pediatr., 93 : 1066, 1978.

• 27) Rowley, J.D., Golomb, H.M. and Vardiman, J.W. : Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood 58 : 759, 1981.
  pubmed

• 28) Keating, M.J., Smith, T.L., McCredie, K.B., Bodey, G.P., Hersh, E.M., Gutterman, J.U., Gehan, E. and Freireich, E.J. : A four-year experience with anthracycline, cytosine arebinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia. Cancer 47 : 2779, 1981.
  pubmed

• 29) Kaneko, Y., Sakurai, M. and Hattori, M. : A case of acute myelogenous leukemia with an 8-21 translocation, a missing Y, and additional karyotypic abnormalities. Am. J. Hematol., 4 : 273, 1978.

• 30) Golomb, H.M., Vardiman, J.W., Rowley, J.D., Testa, J.R. and Mintz, U. : Correlation of clinical findings with quinacrinebanded chromosomes in 90 adults with acute nonlymphocytic leukemia. N. Engl. J. Med., 299 : 613, 1978.
  pubmed

• 31) Rowley, J.D. : Human oncogene locations and chromosome aberrations. Nature 301 : 290, 1983.
  pubmed

P.157 掲載の参考文献

• 1) Ohno, R. et al : Cancer 36 : 1945, 1976.

• 2) Uzuka, Y. et al : Tohoka. J. Exp. Med., 118 : 212, 1979.

• 3) McCredie, K.B. et al : Cancer 47 : 1256, 1981.
  pubmed

• 4) Gale R.P. et al. : Lancet 1 : 497, 1977.
  pubmed

• 5) Aoshima, M. et al : Cancer Res., 37 : 2481, 1977.
  pubmed

• 6) Lister, T.A. et al : Seminar. Hematolo., 19 : 172, 198.

• 7) Vaughan, W.P. et al : Cancer 45 : 859, 1980.
  pubmed

• 8) Dahl, G.V. : Blood 60 : 856, 1982.
  pubmed

• 9) 川島康平・他 : 日血会誌 45 : 579, 1982.

• 10) Simone, JV. : Cancer. Res., 39 : 4301, 1979.
  pubmed

P.168 掲載の参考文献

• 1) Eys, J.V. and Sullivan, M.P. : Status of the curability of childhood cancer. Reven Press, New York, 1980.

• 2) Kumar, A.M. et al : Preoperative therapy for unresectable malignant tumors in children. J. Pediat. Surg. , 10 : 657, 1975.

• 3) Grosfeld, J.L. et al : Experience with second-look operations in pediatric solid tumors. J. Pediat. Surg., 13 : 275, 1978.
  pubmed

• 4) 内野純一・他 : 神経芽腫の治療における二期手術. 小児外科 14 : 373, 1982.

• 5) Uchino, J., Une, Y., Sasaki, F., et al : High-dose cyclophosphamide treatment for patients with advanced neuroblastoma. In Paybaud, C. : Pediatric Oncology, p. 161, Excerpta Medica, Amsterdam, 1982.

• 6) 豊坂昭弘, 岡本英三 : 小児固型悪性腫瘍に対するsecond-look手術-特に小児肝癌について-. 日癌治会誌 18 : 756, 1983.

• 7) Smith, E. I. et al : The impact of chemotherapy and radiation therapy on secondary operations for neuroblastoma. Ann. Surg., 191 : 561, 1980.
  pubmed

• 8) Stanley-Brown, E.G. et al : Second-look operation for retroperitioneal cancer In childhood. New York. J. Med., 71 : 674, 1971.

• 9) 内野純一, 佐々木文章, 宇根良衛・他 : 神経芽腫の治療における二期手術 (second-look operation). 小児外科 14 : 373, 1982.

• 10) 内野純一, 秦 温信, 佐々木文章・他 : 進行性神経芽腫に対する cyclophosphamide 大量療法と second-look operation. 小児外科 14 : 1467, 1982.

• 11) 内野純一 : 両側性Wilms腫瘍の治療方針. 今日の臨床外科 14 : 21-40, メジカルビュー社 東京, 1978.

• 12) Uchino, J., Hata, Y. and Kasai, Y. : IVs neuroblastoma J. Pediatr. Surg., 13 : 167, 172 1978.

• 13) 内野純一, 佐々木文章 : 小児悪性腫瘍の補助療法. 外科治療 46 : 301, 1982.

• 14) 内野純一・他 : 進行性神経芽腫に対する cyclophosphamide 大量療法と second-look operation. 小児外科 83 : 927, 1982.

• 15) Pritchard, J., McElwain and Grahmpole, J. : Highdose melphalan with autologous marrow for treatment of advanced neuroblastoma. Brit. J. Cancer, 45 : 86, 1982.
  pubmed

P.197 掲載の参考文献

• 1) Thomas ED, Storb R, Clift RA. et al : Bone-marrow transplantation. N. Engl. J. Med., 292 : 832, 895, 1975.

• 2) Gale RP : Progress in bone marrow transplantation in man. Sur. Immunol. Res., 1 : 40, 1982.

• 3) Storb R, Thomas ED : Allogeneie bone marrow transplantation. Immunological. Rev., 71 : 77, 1982.

• 4) 服部絢一 : 骨髄移植. 19頁, 中外医学社, 東京, 1983.

• 5) Gale RP : Autologous bone marrow transplantation in patients with cancer. JAMA 243 : 540, 1980.
  pubmed

• 6) Harada M, Yoshida T, Funada H. et al : Allogeneic bone marrow transplantation for the treatment of acute leukemia : The Kanazawa experience. Jpn. J. Clin. Oncol., 12 : 301, 1982.

• 7) Thomas ED, Buckner CD, Clift RA, et al : Marrow transplantation for acute non-lymphoblastic leukemia in first remission. N. Engl. J. Med., 301 : 597, 1979.

• 8) Thomas ED, Sanders JE, Flournoy N. et al : Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54 : 468, 1979.
  pubmed

• 9) Odaka K, Harada M, Koshino T, et al : Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first remission. A case report. Acta Haematol : in press.

• 10) Badger C, Buckner CD, Thomas CD. et al : Allogeneic marrow transplantation for acute leukemia in relapse. Leuk. Ress., 6 : 383, 1982.

• 11) Thomas ED : The role of marrow transplantation in the eradication of malignant disease. Cancer 49 : 1963, 1982.
  pubmed

• 12) Grouse LD, Young RK : Bone marrow transplantation. A lifesaving applied art. An interview with E. Donall Thomas, MD. JAMA 249 : 2528, 1983.

• 13) Thomas ED : Acute myeolgenous leukemia. J. Cell. Biochem (Suppl.) 7A : 44, 1983 (Abstract).

• 14) Appelbaum FR, Buckner CD. et al : Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61 : 949, 1983.
  pubmed

• 15) Thomas ED, Clift RA, Hersman J. et al : Marrow transplantation for acute nonlymphoblastic leukemia in first remission using fractionated or single-dose irradiation. Int. J. Radiation. Oncology. Biol. Phys., 8 : 817, 1982.
  pubmed

• 16) Weiden PL, Sullivan KM, Flournoy N. et al : Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med., 304 : 1529, 1981.
  pubmed

• 17) Hattori K, Harada M, Yoshida T. et al : A preliminary report on autologous bone marrow transplantation for the treatment of advanced non-Hodgkin's lymphoma. Jpn. J. Clin. Oncol., 12 : 171, 1982.

• 18) Harada M. Yoshida H, Funada H, et al : Combined-modality therapy and autologous bone marrow transplantation in the treatment of advanced non-Hodgkin's lymphoma and solid tumor : The Kanazawa experience. Transplant. Proc., 14 : 733, 1982.

• 19) Ritz J. Sallan SE, Bast RC, et al : Autologous bone marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 22 : 60, 1982.

P.206 掲載の参考文献

• 1) Thomas, E.D. et al : N. Engl. J. Med., 292 : 832, 895, 1975.

• 2) Thomas, E.D. et al : Blood 54 : 468, 1979.
  pubmed

• 3) Thomas, E.D. et al : Cancer Treatment Reports, 66 : 1463, 1982.
  pubmed

• 4) Gale, R.P. : Sur. Immunol. Res., 1 : 40, 1982.

• 5) 中村 忍 : 骨髄移植の臨床経験. 臨床血液 21 : 465, 1980.

• 6) 柴川弘俊, 正岡 徹 : 骨髄移植の臨床経験. 臨床血液 21 : 472, 1980.

• 7) 山田一正 : 骨髄移植の臨床的研究. 臨床血液 21 : 457, 1980.

• 8) 井上俊彦 : 再生不良性貧血に対する Total lymphoid irradiation-1回大量照射について. 移植 16 : 318, 1981.

• 9) A. Takamizawa et al : J. Amer. Chem. Soc. 95 : 985-986, 1973.

• 10) H. Kaiser et al : in Modern Trends in Human Leukemia V. pp. 90-91, 1983.

• 11) I. Royston, et al : J. Immunol. 125 : 725-731, 1980.